Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant measles virus expressing zika virus prM and E proteins

Recombinant measles virus expressing zika virus prM and E proteins

US Patent 11857616 · Granted Jan 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid vaccine against the SARS-CoV-2 coronavirus2025
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2024
Lassa vaccine2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2024
Zika virus chimeric polyepitope comprising non-structural proteins and its use i2024
Nucleic acid vaccine against the SARS-CoV-2 coronavirus2023
Recombinant measles vaccine expressing hTERT2022
Zika virus chimeric polyepitope comprising non-structural proteins and its use i2022
Live recombinant measles-M2 virus—its use in eliciting immunity against influenz2021